Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Change in Inventory (2016 - 2025)

Sonoma Pharmaceuticals has reported Change in Inventory over the past 16 years, most recently at $40000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 87.06% year-over-year to $40000.0; the TTM value through Dec 2025 reached $193000.0, down 51.99%, while the annual FY2025 figure was $388000.0, 310.87% up from the prior year.
  • Change in Inventory for Q4 2025 was $40000.0 at Sonoma Pharmaceuticals, up from -$208000.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $652000.0 in Q2 2025 and troughed at -$338000.0 in Q1 2021.
  • A 5-year average of $22500.0 and a median of -$30000.0 in 2021 define the central range for Change in Inventory.
  • Biggest five-year swings in Change in Inventory: surged 1844.44% in 2022 and later tumbled 231.43% in 2023.
  • Year by year, Change in Inventory stood at $426000.0 in 2021, then plummeted by 166.9% to -$285000.0 in 2022, then surged by 274.04% to $496000.0 in 2023, then tumbled by 37.7% to $309000.0 in 2024, then crashed by 87.06% to $40000.0 in 2025.
  • Business Quant data shows Change in Inventory for SNOA at $40000.0 in Q4 2025, -$208000.0 in Q3 2025, and $652000.0 in Q2 2025.